# XMax Inc.: Form 10-Q for the period ended Sep 30, 2019

- Company: [XMax Inc.](/companies/xmax.md) (CIK 1473334)
- Form: 10-Q
- Filed: 2019-11-12
- Accepted by EDGAR: Nov 12, 2019, 16:32 ET
- Period: 2019-09-30
- Accession: 0001185185-19-001566
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1473334/000118518519001566/novalife20190930_10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1473334/000118518519001566/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2019-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2019-07-01 to 2019-09-30 | $9.3m | us-gaap:Revenues |
| Revenue | 9 months, 2019-01-01 to 2019-09-30 | $24.6m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2019-07-01 to 2019-09-30 | $7.8m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months, 2019-01-01 to 2019-09-30 | $20.0m | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2019-07-01 to 2019-09-30 | $1.6m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2019-01-01 to 2019-09-30 | $4.5m | us-gaap:GrossProfit |
| Research and development | 3 months, 2019-07-01 to 2019-09-30 | $29.9k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2019-07-01 to 2019-09-30 | −$369.5k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2019-01-01 to 2019-09-30 | −$1.3m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2019-07-01 to 2019-09-30 | −$11.9k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2019-01-01 to 2019-09-30 | −$782.4k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2019-07-01 to 2019-09-30 | −$396.1k | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2019-01-01 to 2019-09-30 | −$581.9k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2019-07-01 to 2019-09-30 | −$0.01 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2019-01-01 to 2019-09-30 | −$0.02 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2019-07-01 to 2019-09-30 | −$0.01 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2019-01-01 to 2019-09-30 | −$0.02 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2019-07-01 to 2019-09-30 | 28,386,099 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2019-01-01 to 2019-09-30 | 28,583,907 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2019-01-01 to 2019-09-30 | $7.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2019-01-01 to 2019-09-30 | $25.9k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months, 2019-01-01 to 2019-09-30 | $515.5k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2019-09-30 | $1.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2019-09-30 | $73.2m | us-gaap:AssetsCurrent |
| Total assets | at 2019-09-30 | $79.9m | us-gaap:Assets |
| Current liabilities | at 2019-09-30 | $1.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2019-09-30 | $5.6m | us-gaap:Liabilities |
| Shareholders' equity | at 2019-09-30 | $74.2m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 51,801 characters.

### Safe Harbor Declaration

*The following discussion and analysis is based upon our financial statements as of the dates and for the periods presented in this section. You should read this discussion and analysis in conjunction with the financial statements and notes thereto found in Part I, Item 1 of this Form 10-Q and our consolidated financial statements and notes thereto included in our annual report on Form 10-K for the fiscal year ended December 31, 2018 (the “2018 Form 10-K”). All references to the third quarter and first nine months of 2019 and 2018 mean the three and nine-month periods ended September 30, 2019 and 2018. In addition to historical information, the following discussion and other parts of this report contain certain forward-looking information. When used in this discussion, the words, “believes,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Such statements are subject to certain risks and uncertainties, which could cause actual results to differ materially from projected results, due to a number of risks, uncertainties and factors beyond our control. We do not undertake to publicly update or revise any of these forward-looking statements, even if experience or future changes show that the indicated results or events will not be realized. Furthermore, we cannot guarantee future results, events, levels of activity, performance, or achievements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Readers also are urged to carefully review and consider our discussions regarding the various factors that affect the company’s business, which are described in this section and elsewhere in this report. For more information, see our discussion of risk factors located at Part I, Item 1A of our 2018 Form 10-K.*

### Overview

Nova LifeStyle, Inc. is a distributor of contemporary styled residential and commercial furniture incorporated into a dynamic marketing and sales platform offering retail as well as online selection and global purchase fulfillment. We monitor popular trends and products to create design elements that are then integrated into our product lines that can be used as both stand-alone or whole-room and home furnishing solutions. Through our global network of retailers, e-commerce platforms, stagers and hospitality providers, Nova LifeStyle also sells (through an exclusive third-party manufacturing partner) a managed variety of high quality bedding foundation components.

Nova LifeStyle’s brand family currently includes Diamond Sofa (www.diamondsofa.com) and Bright Swallow.

Our customers principally consist of distributors and retailers with specific geographic territories that deploy middle to high end private label home furnishings which have very little competitive overlap with our specific furnishing products or product lines. Nova LifeStyle is constantly seeking to integrate new sources of distribution and manufacturing that are properly aligned with our growth strategy. This allows us to continually focus on building both our overall distribution and manufacturing relationships through a deployment of popular, as well as trend-based, furnishing solutions worldwide.

We are a U.S. holding company with no material assets in the U.S. other than the ownership interests of our wholly owned subsidiaries through which we market, design and sell residential furniture worldwide: Nova Furniture Macao Commercial Offshore Limited, Bright Swallow International Group Limited, and Diamond Bar Outdoors, Inc. Nova Macao was organized under the laws of Macao on May 20, 2006. Nova Macao is a wholly owned subsidiary of Nova Lifestyle. Diamond Bar is a California corporation organized on June 15, 2000, which we acquired pursuant to a stock purchase agreement on August 31, 2011. On April 24, 2013, we acquired all of the outstanding stock of Bright Swallow. On December 7, 2017, we incorporated i Design Blockchain Technology, Inc. (“i Design”) under the laws of the State of California. The purpose of i Design is to build our own blockchain technology team. This company is in the planning stage and has had minimal operations to date.

Our experience developing and marketing products for international markets has enabled us to develop the scale, logistics, marketing, manufacturing efficiencies and design expertise that serve as the foundation for us to expand aggressively into the highly attractive U.S., Canadian, European, Australian, Asian and Middle Eastern markets.

Due to the recent imposition of significant trade tariffs on importation from China to United States, we are actively pursuing alternative product lines with positive growth potential. One of such areas pertains to the health-oriented furniture segment which continues to experience popularity, particularly in Asia. Since the second quarter of 2019, we have developed a line of high-end physiotherapeutic jade mats with China based manufacturing partners for use in therapy clinics, hospitality, and real estate projects in Asia. We are in the process of launching our first flagship retail store in Kuala Lumpur, Malaysia, which is expected to open by the end of 2019 and will serve as one of our primary distribution channels. Marketing of jade mats will focus on their premium therapeutic qualities and target health conscious general consumers and professionals.

### Principal Factors Affecting Our Financial Performance

At the beginning of 2019 we commenced a transition of our business. We began moving away from low cost, low margin products to a mix of products that appeal to a higher-end ultimate consumer. This move is intended to improve our gross profit margin, receivable collections and net profitability, and to increase our return on long-term equity, over the long-term. We decided to terminate sales and marketing efforts to customers that represented a high purchase volume but low profit margin, and we adjusted our product line, which included the launch of our Summer 2019 Collection in the Las Vegas Market, with a view to attracting a higher-end ultimate customer. We believe these new strategies, and the recent launch of our Summer 2019 Collection, will provide us with significant long term growth opportunities. The transition is expected to continue to adversely impact our revenue and our net profit in the short-term as we roll out new products and market those products to our existing client base and to new potential customers better suited for the higher end products, and as we assess our new products’ market acceptance. Significant factors that we believe could affect our operating results are the (i) prices of our products to our international retailer and wholesaler customers and their markups to end consumers; (ii) consumer acceptance of our new brands and product collections; (iii) general economic conditions in the U.S., Chinese, Canadian, European and other international markets; and (iv) trade tariffs imposed by the United States on certain products manufactured in China. We believe most of our customers are willing to pay higher prices for our high quality and stylish products, timely delivery, and strong production capacity, which we expect will allow us to maintain high gross profit margins for our products. We do not manufacture our products, rather we utilize third party manufacturers. In response to the tariffs imposed by the United States on certain products manufactured in China, we are attempting to shift a portion of our product manufacturing from third party manufacturers located in China to third party manufacturers located in other parts of Asia, such as Vietnam, India and/or Malaysia, countries unaffected by the tariffs. Implementation of a relocation of manufacturing (which by necessity includes an assessment of the factory’s ability to deliver the quantity of the product, in accordance with the Company’s specifications, and in accordance with the Company’s quality control requirements) is time-consuming, but we expect that a portion of our manufacturing will be transitioned to one or more of these venues during 2019. Some of our manufacturing will continue to be performed in China because the intellectual know-how necessary to manufacture certain products is not generally available in other Asian countries. Consumer preference trends favoring high quality and stylish products and lifestyle-based furniture suites should also allow us to maintain our high gross profit margins. The markets in North America (excluding the United States) and particularly in Europe remain challenging because such markets are experiencing a slower than anticipated recovery from the international financial crisis. However, we believe that discretionary purchases of furniture by middle to upper middle-income consumers, our target global consumer market, will increase along with expected growth in the worldwide furniture trade and the recovery of housing markets. Furthermore, we believe that our expansion of direct sales in the U.S. will have a positive impact on our net sales and net income, while helping to diversify our customer base and end consumer markets.

Due to the recent imposition of significant trade tariffs on importation from China to United States, we are actively pursuing alternative product lines with positive growth potential. One of such areas pertains to the health-oriented furniture segment which continues to experience popularity, particularly in Asia. Since the second quarter of 2019, we have developed a line of high-end physiotherapeutic jade mats with China based manufacturing partners for use in therapy clinics, hospitality, and real estate projects in Asia. We are in the process of launching our first flagship retail store in Kuala Lumpur, Malaysia, which is expected to open by the end of 2019 and will serve as one of our primary distribution channels. Marketing of jade mats will focus on their premium therapeutic qualities and target health conscious general consumers and professionals. We have limited experience with operations in Southeast Asia and considerable management attention and resources may be required to manage these new markets and product lines. We may be subject to additional risks including credit risk, currency exchange rate fluctuations, foreign exchange controls, import and export requirements, potentially adverse tax consequences and higher costs associated with doing business internationally.

### Critical Accounting Policies

While our significant accounting policies are described more fully in Note 2 to our accompanying unaudited condensed consolidated financial statements, we believe the following accounting policies are the most critical to aid you in fully understanding and evaluating this Management’s Discussion and Analysis.

There have been no material changes to our critical accounting policies and estimates as compared to the critical accounting policies and estimates described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018.

On January 1, 2019, we adopted Accounting Standards Update No. 2016-02, Leases (Topic 842) (ASU 2016-02), as amended, which supersedes the lease accounting guidance under Topic 840, and generally requires lessees to recognize operating and financing lease liabilities and corresponding right-of-use (ROU) assets on the balance sheet and to provide enhanced disclosures surrounding the amount, timing and uncertainty of cash flows arising from leasing arrangements. We adopted the new guidance using the modified retrospective transition approach by applying the new standard to all leases existing at the date of initial application and not restating comparative periods. The most significant impact was the recognition of ROU assets and lease liabilities for operating leases. See Note 2— Summary of Significant Accounting Policies and Note 12 — Commitments and Contingencies in the notes to the condensed consolidated financial statements included in Part I, Item 1, of this Quarterly Report on Form 10-Q for additional information regarding the adoption.

### Basis of Presentation

The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for Nova LifeStyle and its subsidiaries, Diamond Bar, Bright Swallow, Nova Macao, i Design, Nova Furniture and Nova Samoa.

### Use of Estimates

In preparing consolidated financial statements in conformity with U.S. GAAP, we make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the consolidated financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions made by us, include but are not limited to, revenue recognition, the allowance for bad debt, valuation of inventories, the valuation of stock-based compensation, income taxes and unrecognized tax benefits, valuation allowance for deferred tax assets, assumptions used in assessing impairment of long-lived assets and goodwill. Actual results could differ from those estimates.

### Accounts Receivable

Our policy is to maintain an allowance for potential credit losses on accounts receivable. We review the composition of accounts receivable and analyze historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. We maintained an allowance for bad debt of $10,185 and $224,795 as of September 30, 2019 and December 31, 2018, respectively. During the three months ended September 30, 2019 and 2018, bad debt expenses were $5,136 and $2,128,579, respectively. During the nine months ended September 30, 2019 and 2018, bad debt (reversal) expenses were ($214,610) and $2,298,488, respectively. As of September 30, 2019, we had gross receivable of $9,032,056, of which $1,371,506 was over 90 days but within 180 days past due. The allowance for doubtful accounts is our best estimate of the amount of probable credit losses in our existing trade accounts receivable. We determine the allowance based on historical bad debt experience, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns.

### Advances to Suppliers

Advances to suppliers are reported net of allowance when we determine that amounts outstanding are not likely to be collected in cash or utilized against purchase of inventories. Based on our historical records, we generally receive goods within 5 to 9 months from the date the advance payment is made. As such, no reserve on supplier prepayments has been made or recorded by us. Any provisions for allowance for advance to suppliers, if deemed necessary, will be included in general and administrative expenses in the consolidated statements of comprehensive income (loss).

### Income Taxes

In our interim financial statements, we follow the guidance in ASC 270 “Interim Reporting” and ASC 740 “Income Taxes” whereby the Company utilizes the expected annual effective rate in determining its income tax provision. The income tax benefits for the nine and three months ended September 30, 2019 of approximately $782,000 and $12,000 are primarily related to a reversal of tax liability reserves due to a statute of limitations expiration in 2019 and quarter-to-date losses generated from U.S. operations. The income tax benefit for the nine and three months ended September 30, 2018 were approximately $505,000 and $942,000 and were primarily related to income from operations.

Income taxes are accounted for using an asset and liability method. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates, applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

We follow ASC Topic 740, which prescribes a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740 also provides guidance on recognition of income tax assets and liabilities, classification of current and deferred income tax assets and liabilities, accounting for interest and penalties associated with tax positions, accounting for income taxes in interim periods, and income tax disclosures.

Under the provisions of ASC Topic 740, when tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. The benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination.

Nova Lifestyle, Inc. and Diamond Bar Outdoors, Inc. (“Diamond Bar”) are subject to U.S. federal and state income taxes. Nova Furniture BVI and Bright Swallow International Group Limited (“BSI”) were incorporated in the BVI, Nova Samoa was incorporated in Samoa and Nova Macau was incorporated in Macau. There is no income tax for companies domiciled in the BVI, Samoa and Macau. Accordingly, the Company’s consolidated financial statements do not present any income tax provisions related to the BVI, Samoa and Macau tax jurisdictions where Nova Furniture BVI and BSI, Nova Samoa and Nova Macau are domiciled.

The Tax Cuts and Jobs Act of 2017 (the “Act”) created new taxes on certain foreign-sourced earnings such as global intangible low-taxed income (“GILTI”) under IRC Section 951A, which is effective for the Company for tax years beginning after January 1, 2018. For the quarter ended September 30, 2019, the Company has calculated its best estimate of the impact of the GILTI in its income tax provision in accordance with its understanding of the Act and guidance available as of the date of this filing.

### Revenue Recognition

We recognize revenues when our customer obtains control of promised goods or services, in an amount that reflects the consideration which it expects to receive in exchange for those goods. We recognize revenues following the five step model prescribed under ASU No. 2014-09: (i) identify contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenues when (or as) we satisfy the performance obligation.

Revenue from product sales is recognized when the customer obtains control of our product, which typically occurs upon delivery to the customer. We expense incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that it would have recognized is one year or less or the amount is immaterial.

Revenue from product sales is recorded net of reserves established for applicable discounts and allowances that are offered within contracts with our customers.

Product revenue reserves, which are classified as a reduction in product revenues, are generally characterized in the following categories: discounts, returns and rebates. These reserves are based on estimates of the amounts earned or to be claimed on the related sales and are classified as reductions of accounts receivable as the amount is payable to our customer.

Our sales policy allows for the return of product within the warranty period if the product is defective and the defects are our fault. As alternatives for the product return option, the customers have the option of asking us for a discount for products with quality issues, or of receiving replacement parts from us at no cost. The amount of reserves for return of products, the discount provided to the customers, and cost for the replacement parts were immaterial for the nine months ended September 30, 2019.

We generally expense sales commissions when incurred because the amortization period would have been one year or less. These costs are recorded within selling expenses on our consolidated statements of comprehensive income (loss).

### Foreign Currency Translation and Transactions

The accompanying consolidated financial statements are presented in United States Dollar (“$” or “USD”), which is also the functional currency of Nova LifeStyle, Nova Furniture, Nova Samoa, Nova Macao, Bright Swallow, Diamond Bar and i Design.

### Segment Reporting

ASC Topic 280, “Segment Reporting,” requires use of the “management approach” model for segment reporting. The management approach model is based on the way a company’s chief operating decision maker organizes segments within the company for making operating decisions, assessing performance and allocating resources. Reportable segments are based on products and services, geography, legal structure, management structure, or any other manner in which management disaggregates a company.

We determined that our operations constitute a single reportable segment in accordance with ASC 280. We operate exclusively in one business and industry segment: the design and sale of furniture.

We concluded that we had one reportable segment under ASC 280 because Diamond Bar is a furniture distributor based in California focusing on customers in the US, Bright Swallow is a furniture distributor focusing on customers primarily in Canada, and Nova Macao is a furniture distributor based in Macao focusing on international customers. Each of our subsidiaries is operated under the same senior management of our company, and we view the operations of Diamond Bar, Bright Swallow and Nova Macao as a whole for making business decisions.

Net sales to customers by geographic area are determined by reference to the physical product shipment delivery locations requested by our customers. For example, if the products are delivered to a customer in the U.S., the sales are recorded as generated in the U.S.; if the customer directs us to ship its products to China, the sales are recorded as sold in China.

### New Accounting Pronouncements

#### Recently issued accounting pronouncements not yet adopted

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326), which requires entities to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. This replaces the existing incurred loss model and is applicable to the measurement of credit losses on financial assets measured at amortized cost. This guidance is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early application will be permitted for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Adoption of the ASUs is on a modified retrospective basis. We are currently evaluating the impact that the standard will have on our consolidated financial statements and related disclosures.

In January 2017, the FASB issued ASU No. 2017-04, simplifying the Test for Goodwill Impairment. The guidance removes Step 2 of the goodwill impairment test, which requires a hypothetical purchase price allocation. A goodwill impairment will now be the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. The guidance should be adopted on a prospective basis for the annual or any interim goodwill impairment tests beginning after December 15, 2019. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. We are currently evaluating the impact of adopting this standard on our consolidated financial statements.

In June 2018, the FASB issued ASU 2018-07, “Compensation — Stock Compensation (Topic 718): Improvements to Non-employee Share-Based Payment Accounting,” which expands the scope of ASC 718 to include share-based payment transactions for acquiring goods and services from non-employees. An entity should apply the requirements of ASC 718 to non-employee awards except for specific guidance on inputs to an option pricing model and the attribution of cost. The amendments specify that ASC 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor's own operations by issuing share-based payment awards. The new guidance is effective for SEC filers for fiscal years beginning after December 15, 2018, and interim reporting periods within those fiscal years (i.e., January 1, 2020, for calendar year entities). Early adoption is permitted. We are evaluating the effects of the adoption of this guidance and currently believe that it will impact the accounting of the share-based awards granted to non-employees.

### Results of Operations

### Comparison of Three Months Ended September 30, 2019 and 2018

The following table sets forth the results of our operations for three months ended September 30, 2019 and 2018. Certain columns may not add due to rounding.

|  | Three Months Ended September 30, 2019 $% of Sales |  | 2018 $% of Sales |  |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $9,322,836 |  | $16,747,827 |  |
| Cost of sales | (7,753,459) | (83%) | (13,529,002) | (81%) |
| Gross profit | 1,569,377 | 17% | 3,218,825 | 19% |
| Operating expenses | (1,938,882) | (21%) | (4,575,628) | (27%) |
| Loss from operations | (369,505) | (4%) | (1,356,803) | (8%) |
| Other expenses, net | (38,558) | (-%) | (77,497) | (-%) |
| Income tax benefit | (11,915) | -% | (942,267) | (6%) |
| Net loss | (396,148) | (4%) | (492,033) | (3%) |

### Net Sales

Net sales for the three months ended September 30, 2019 were $9.32 million, a decrease of 44.33% from $16.75 million in the same period of 2018. This decrease in net sales resulted primarily from a 28.05% decrease in sales volume and 22.63% decrease in average selling price. Our largest selling product categories in the three months ended September 30, 2019 were sofas, decorations and beds, which accounted for approximately 74%, 5% and 3% of sales, respectively. In the three months ended September 30, 2018, the largest three selling categories were sofas, cabinets and beds, which accounted for approximately 64%, 10% and 9% of sales, respectively.

Our revenue has been adversely impacted by two factors, (a) our decisions to move away from low cost, low margin products to a mix of products that appeal to a higher-end ultimate consumer and to eliminate customers generating low margin sales and customers that have slow payment histories, and (b) the increased trade tariffs imposed by the United States on products manufactured in China. The trade tariffs imposed by the United States would have effectively reduced or eliminated our gross margin on our low cost, low margin products, which in part drove our decision to move away from those products. The resulting shift from those low cost, low margin products caused certain of our distributors that historically had represented a significant portion of our revenue to move their business to other providers. The $7.42 million decrease in net sales in the three months ended September 30, 2019, compared to the same period of 2018, was mainly due to decreased sales to Australia, Asia, and North America. Sales to North America were $4.25 million in the three months ended September 30, 2019, a decrease of 67.9% from $13.24 million in 2018, primarily due to the trade war tariffs, which took effect in September 2018 and have caused a significant number of our sales orders to be held up. We also temporarily eliminated sales to customers generating high volume but low profit margin sales. Sales to Asia, excluding China, decreased 100% to $0 million in the three months ended September 30, 2019, compared to $2.82 million in the same period of 2018. Australia sales also decreased 100% to $0 million in the three months ended September 30, 2019, compared to $0.55 million in 2018. We stopped selling to customers from which it took us a long time to collect our accounts receivable. We thus ceased our marketing efforts in these regions altogether. We changed our sales strategy to seek sales of high margin products and shorter collection time on the customers’ accounts receivable. See the discussion of our tightened credit terms below under the heading *Liquidity and Capital Resources.* China sales were $4.96 million in the three months ended September 30, 2019, compared to $0 million in 2018, primarily as a result of increasing sales orders from one of our customers in China. Sales to other countries decreased to $0.12 million in the three months ended September 30, 2019, compared to $0.15 million in 2018, primarily due to receiving fewer sales orders from customers.

### Cost of Sales

Cost of sales consists primarily of costs of finished goods purchased from third-party manufacturers. Total cost of sales decreased by 43% to $7.75 million in the three months ended September 30, 2019, compared to $13.53 million in the same period of 2018. Cost of sales as a percentage of sales increased to 83% in the three months ended September 30, 2019, compared to 81% in the same period of 2018. The decrease of cost of sales in dollars is primarily due to decreased sales. The increase in cost of sales as a percentage of sales is primarily a result of the increased cost of products purchased from third parties, which have increased our costs and reduced our profit margin for sales to certain customers.

### Gross Profit

Gross profit decreased by 51% to $1.57 million in the three months ended September 30, 2019, compared to $3.22 million in the same period of 2018. Our gross profit margin decreased to 17% in the three months ended September 30, 2019, compared to 19% in the same period of 2018. The decrease in gross profit margin was mainly due to the increased cost of products purchased from third-party manufacturers and high tariffs on products from China.

### Operating Expenses

Operating expenses consisted of selling, general and administrative expenses and research and development expenses. Operating expenses were $1.94 million in the three months ended September 30, 2019, compared to $4.58 million in the same period of 2018. Selling expenses decreased by 55%, or $0.47 million, to $0.38 million in the three months ended September 30, 2019, from $0.85 million in the same period of 2018, due primarily to decreased sales commissions, marketing, advertising and show expenses. General and administrative expenses decreased by 58%, or $2.16 million, to $1.56 million in the three months ended September 30, 2019, from $3.72 million in the same period of 2018, primarily due to a decrease in travel and entertainment expense of $0.12 million and bad debt expense of $2.12 million.

### Other Expenses, Net

Other expenses, net, was $38,558 in the three months ended September 30, 2019, compared with other expenses, net, of $77,497 in the same period of 2018, representing a decrease in other expenses of $38,939. The decrease in other expenses was due primarily to the decreased interest expense on our lines of credit to $0 in the three months ended September 30, 2019 from $36,696 in the same period of 2018. We recorded a higher interest income on our increased average balances at banks in 2019. Interest income was $400 and $66 for the three months ended September 30, 2019 and 2018, respectively. Also, there was a decrease in non-operating expenses of $3,486 to $0, from $3,486 in the same period of 2018.

### Income Tax Benefit

Income tax benefit was $11,915 in the three months ended September 30, 2019, compared with $942,267 of income tax benefit in the same period of 2018. The decrease in income tax benefit for the three months ended September 30, 2019 was primarily related to a decreased reversal of tax liability due to a statute of limitation expiration, compared with the same period of 2018.

### Net Loss

As a result of the foregoing, our net loss was $0.40 million in the three months ended September 30, 2019, as compared with $0.49 million of net loss for the same period of 2018.

### Comparison of Nine months Ended September 30, 2019 and 2018

The following table sets forth the results of our operations for the nine months ended September 30, 2019 and 2018. Certain columns may not add due to rounding.

|  | Nine months Ended September 30, 2019 $% of Sales |  | 2018 $% of Sales |  |
| --- | ---: | ---: | ---: | ---: |
| Net sales | 24,577,846 |  | 63,159,929 |  |
| Cost of sales | (20,029,298) | (81%) | (50,834,321) | (80%) |
| Gross profit | 4,548,548 | 19% | 12,325,608 | 20% |
| Operating expenses | (5,858,447) | (24%) | (10,105,250) | (16%) |
| (Loss) Income from operations | (1,309,899) | (5%) | 2,220,358 | 4% |
| Other expenses, net | (54,327) | (-%) | (199,139) | (-%) |
| Income tax benefit | (782,362) | (3%) | (505,074) | (1%) |
| Net (loss) income | (581,864) | (2%) | 2,526,293 | 4% |

### Net Sales

Net sales for the nine months ended September 30, 2019 were $24.58 million, a decrease of 61% from $63.16 million in the same period of 2018; this decrease in net sales resulted primarily from a 35.97% decrease in sales volume and 39.20% decrease in average selling price. Our largest selling product categories in the nine months ended September 30, 2019 were sofas, cabinets and beds, which accounted for approximately 61%, 11% and 5% of sales, respectively. In the nine months ended September 30, 2018, the largest three selling categories were sofas, TV cabinets and beds, which accounted for approximately 59%, 8% and 7% of sales, respectively.

Our revenue has been adversely impacted by two factors: (a) our decision to move away from low cost, low margin products to a mix of products that appeal to a higher-end ultimate consumer and to eliminate customers generating low margin sales and customers that have slow payment histories, and (b) the increased trade tariffs imposed by the United States on products manufactured in China. The trade tariffs imposed by the United States would have effectively reduced or eliminated our gross margin on our low cost, low margin products, which in part drove our decision to move away from those products. The resulting shift from those low cost, low margin products caused certain of our distributors that historically had represented a significant portion of our revenue to move their business to other providers. The $38.58 million decrease in net sales in the nine months ended September 30, 2019, compared to the same period of 2018, includes a $27.85 million decrease in sales in North America, an $11.08 million decrease in sales in Australia and an $11.68 million decrease in sales in Asia, offset by a $11.79 million increase in sales in China and a $0.23 million increase in sales in other countries. North American sales decreased by 69.2% to $12.37 million in the nine months ended September 30, 2019, compared to $40.22 million in 2018. Due to higher tariffs, we have temporarily stopped taking orders from customers with low margins. Australia sales were $0 in the nine months ended September 30, 2019, compared to $11.08 million in the same period of 2018. Sales to Asia, excluding China, decreased by 100% to $0 million in the nine months ended September 30, 2019, compared to $11.68 million in the same period of 2018. We stopped selling to customers with long collection time on their accounts receivable and ceased our marketing efforts in these regions. We changed our sales strategy to aim for sales of high margin products and shorter collection times on the customers’ accounts receivable. China sales were $11.79 million in nine months ended September 30, 2019, compared to $0 million in 2018, primarily as a result of increasing sales orders from one of our customers in China. Sales to other countries also increased to $0.41 million in the nine months ended September 30, 2019, compared to $0.18 million in sales in 2018, primarily due to an increase in sales orders from two customers in New Zealand.

### Cost of Sales

Cost of sales consists primarily of finished goods purchased from other manufacturers. Total cost of sales decreased 61% to $20.03 million in the nine months ended September 30, 2019, compared to $50.83 million in the same period of 2018. Cost of sales as a percentage of sales was 81% and 80% in the nine months ended September 30, 2019 and 2018, respectively. The increase in cost of sales as a percentage of sales resulted primarily a result of the increased cost of products purchased from third parties, which have increased our costs and reduced our profit margin for sales to certain customers. The decrease of cost of sales in dollar terms is primarily due to the decreased sales.

### Gross Profit

Gross profit decreased 63% to $4.55 million in the nine months ended September 30, 2019, compared to $12.33 million in the same period of 2018. Our gross profit margin was 19% and 20% in the nine months ended September 30, 2019 and 2018, respectively. The decrease in gross profit in dollar terms resulted primarily from decreased sales in 2019.

### Operating Expenses

Operating expenses consist of selling, general and administrative expenses and research and development expenses. Operating expenses were $5.86 million in the nine months ended September 30, 2019, compared to $10.11 million in the same period of 2018. Selling expenses decreased by 53% to $1.19 million in the nine months ended September 30, 2019, from $2.53 million in the same period of 2018, due primarily to decreased sales commissions, marketing, advertising and show expenses. General and administrative expenses decreased 38% to $4.67 million in the nine months ended September 30, 2019, from $7.57 million in the same period of 2018, primarily due to a decrease in bad debt expense of $2.51 million, and a decrease in travel and entertainment expense of 0.32 million.

### Other Expenses, Net

Other expenses, net was $54,327 in the nine months ended September 30, 2019, compared with other expenses, net, of $199,139 in the same period of 2018, representing a decrease in other expenses of $0.14 million. Interest expense decreased by $57,080 due to a lower average balance of our lines of credit in the nine months ended September 30, 2019. We recorded a higher interest income on our increased average balances at banks in 2019. Interest income was $61,238 and $108 for the nine months ended September 30, 2019 and 2018, respectively. Also, there was an increase in non-operating income of $37,319 to $37,915, from $596 in the same period of 2018.

### Income Tax Benefit

Income tax benefit was $782,362 in the nine months ended September 30, 2019, compared with $505,074 of income tax benefit in the same period of 2018. The increase in income tax benefit for the nine months ended September 30, 2019 was primarily related to a reversal of tax liability reserves due to a statute of limitations expiration in 2019 and losses generated from U.S. operations in the nine months ended September 30, 2019.

### Net (Loss) Income

As a result of the foregoing, our net loss was $0.58 million in the nine months ended September 30, 2019, as compared with $2.53 million of net income for the same period of 2018.

### Liquidity and Capital Resources

Our principal demands for liquidity are related to our efforts to increase sales, and to purchase inventory, and for expenditures related to sales distribution and general corporate purposes. We intend to meet our liquidity requirements, including capital expenditures related to purchase of inventories and the expansion of our business, primarily through cash flow provided by operations, collections of accounts receivable, and credit facilities from banks.

We rely primarily on internally generated cash flow and proceeds under credit facilities to support growth. We may seek additional financing in the form of bank loans or other credit facilities or funds raised through future offerings of our equity or debt, if and when we determine such offerings are required. As of September 30, 2019, we do not have any credit facilities.

We had net working capital of $71,839,882 at September 30, 2019, a decrease of $1,776,831 from net working capital of $73,616,713 at December 31, 2018. The ratio of current assets to current liabilities was 53.88-to-1 at September 30, 2019.

The following is a summary of cash provided by or used in each of the indicated types of activities during the nine months ended September 30, 2019 and 2018:

| Cash provided by (used in): | 2019 | 2018 |
| --- | ---: | ---: |
| Operating activities | $7,714,272 | $(5,507,015) |
| Investing activities | (25,902) | (12,960) |
| Financing activities | (6,763,616) | 681,207 |

36

Net cash provided by operating activities was $7.71 million in the nine months ended September 30, 2019, an increase of cash inflow of $13.22 million from $5.51 million of cash used in operating activities in the same period of 2018. The increase of cash inflow was attributable primarily to an increased cash inflow of $60.66 million from accounts receivable to $58.65 million cash inflow in the nine months ended September 30, 2019, compared to $2.01 million cash outflow in the same period of 2018, such increase being primarily due to collected accounts receivable from our customers. In past years, we had allowed our key customers to take longer than the granted credit periods to settle their purchases, in order to boost sales. Starting from the second half of 2018, we had been monitoring them closely for payment but our accounts receivable still reached a record high of $67.5 million as of December 31, 2018, and this negatively impacted to our cash flow from operating activities. In 2019, the industry environment worsened as a result of the imposition by the U.S. of tariffs on products manufactured in China. We determined not to accept new sales orders from those key customers until they settled all overdue balances. As a result of customer payments and the significant reduction in sales, we were able to reduce our accounts receivable balance by approximately $58.44 million in the first three quarters of 2019. We will continue our efforts to tighten customers’ credit terms and expect that most of our customers will pay according to the contract terms going forward. The increase in operating cash inflow was partially offset by the increase in cash outflow for advances to suppliers of $14.86 million to $26.00 million cash outflow in the nine months ended September 30, 2019, compared to $11.14 million cash outflow in the same period of 2018; and by the increase in cash outflow for inventory of $19.56 million to $18.97 million cash outflow in the nine months ended September 30, 2019, compared to $0.59 million cash inflow in the same period of 2018.

Due to the recent imposition of significant trade tariffs on importation from China to the United States, we are actively developing alternative markets and product lines. We have been developing relationships with potential customers in Asia who intend to purchase high-end health furniture products for use in therapy clinics, hospitality and real estate projects. We have also been networking with sales agents to develop these markets. In the second quarter of 2019, we sourced physiotherapeutic jade mats from manufacturers in China. As of September 30, 2019, we had advanced deposits for approximately $35.7 million in order to procure the products. These advances can ensure that our products are prioritized and help lock in purchase prices and bulk purchase discounts with our suppliers. We expect to receive these products within the year.

The operating cash flow is also negatively impacted by the increase in cash outflow for accounts payable of $5.50 million to $3.69 million in cash outflow in the nine months ended September 30, 2019, compared to $1.81 million in cash inflow in the same period of 2018, such increase being mainly due to more timely payments to suppliers; and the increase in cash outflow for tax payable of $1.28 million to $2.02 million cash outflow in the nine months ended September 30, 2019, compared to $0.73 million cash outflow in the same period of 2018, such increase in cash outflows being mainly a result of $2.01 million of one-time transition tax recognized in the fourth quarter of 2017.

Net cash used in investing activities was $25,902 in the nine months ended September 30, 2019, an increase of cash outflow of $12,942 from $12,960 in outflow in the same period of 2018. In the nine months ended September 30, 2019 and 2018, we incurred cash outflow of $25,902 and $12,960 from purchases of property and equipment, respectively.

Net cash used in financing activities was $6.76 million in the nine months ended September 30, 2019, an increase of cash outflow of $7.4 million from cash inflow of $0.68 million in the same period of 2018. In the nine months ended September 30, 2019, we repaid $23.76 million in bank loans and borrowed $17.51 million in bank loans, while repurchasing common stock for $515,455. In the nine months ended September 30, 2018, we repaid $55.41 million in bank loans, and borrowed $56.06 million in bank loans, while cash received from exercise of options for common stock was $31,500.

As of September 30, 2019, we had gross accounts receivable of $9,032,056, of which $6,805,268 was not yet past due, $855,282 was fewer than 90 days past due and $1,371,506 was over 90 days but within 180 days past due. We had an allowance for bad debt of $10,185. As of November 1, 2019, $1,206,851 accounts receivable outstanding at September 30, 2019 had been collected.

All accounts receivable outstanding at December 31, 2018 had been collected during 2019.

As of September 30, 2019 and December 31, 2018, we had advances to suppliers of $36,623,592 and $10,625,021, respectively. These supplier prepayments are made for goods before we actually receive them. The balance of advances to suppliers has increased by $25.99 million, mainly a result of making deposits of $35.7 million with suppliers who manufacture physiotherapeutic jade mats in China.

For a new product, the normal lead time from new product R&D, prototype, and mass production to delivery of goods from our suppliers to us is approximately six to nine months after we make advance payments to our suppliers. For other products, the typical time is five months after our advance payment. We will consider the need for a reserve when and if a supplier fails to fulfill our orders within the time frame as stipulated in the purchase contracts. As of September 30, 2019 and December 31, 2018, no reserve on supplier prepayments had been made or recorded by us.

As of November 1, 2019, $8,142,739, or 22.2%, of our advances to suppliers outstanding at September 30, 2019 had been delivered to us in the form of inventory purchases.

Most of the remaining balance of $28,480,853 in advances to suppliers outstanding at September 30, 2019 is expected to be delivered to us in the form of inventory purchases through the fourth quarter of 2019.

### Lines of Credit

On September 19, 2017, Diamond Bar extended the line of credit up to a maximum of $8,000,000 to mature on June 1, 2019. The annual interest rate was 5.50% as of September 30, 2019. The line of credit is secured by all of the assets of Diamond Bar and is guaranteed by Nova LifeStyle. As of September 30, 2019 and December 31, 2018, Diamond Bar had $0 and $6,248,162 outstanding on the line of credit, respectively. During the nine months ended September 30, 2019 and 2018, the Company recorded interest expense of $35,444 and $92,524, respectively; and $0 and $36,696 for the three months ended September 30, 2019 and 2018, respectively. We paid off the lines of credit during the nine months ended September 30, 2019.

As of September 30, 2019, we do not have any credit facilities.

The Diamond Bar loan had the following covenants: (i) maintain a minimum tangible net worth of not less than $20 million; (ii) maintain a ratio of debt to tangible net worth not in excess of 2.5 to 1.0; (iii) the pre-tax income must not be less than 1% of total quarterly revenue; and (iv) maintain a current ratio in excess of 1.25 to 1.00. As of December 31, 2018, Diamond Bar was in compliance with the stated covenants.

### Shelf Registration; Resale Registration Statement

On July 13, 2017, the Company filed a shelf registration statement on Form S-3 under which the Company may, from time to time, sell securities in one or more offerings up to a total dollar amount of $60,000,000. The shelf registration statement was declared effective as of October 12, 2017.

### Other Long-Term Liabilities

As of September 30, 2019, we recorded long-term taxes payable of $1.93 million, consisting of an income tax payable of $1.82 million, primarily arising from a one-time transition tax recognized in the fourth quarter of 2017 on our post-1986 foreign unremitted earnings, and a $0.11 million unrecognized tax benefit, as ASC 740 specifies that tax positions for which the timing of the ultimate resolution is uncertain should be recognized as long-term liabilities.

We elected to pay the one-time transition tax over the eight years commencing April 2018.

### Off-Balance Sheet Arrangements

There are no off-balance sheet arrangements between us and any other entity that have, or are reasonably likely to have, a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to shareholders.

We have not entered into any other financial guarantees or other commitments to guarantee the payment obligations of any third parties. We have not entered into any derivative contracts that are indexed to our shares and classified as stockholders’ equity or that are not reflected in our consolidated financial statements. Furthermore, we do not have any retained or contingent interest in assets transferred to an unconsolidated entity that serves as credit, liquidity or market risk support to such entity. We do not have any variable interest in any unconsolidated entity that provides financing, liquidity, market risk or credit support to us or engages in leasing, hedging or research and development services with us.

## Controls and procedures

As filed, 1,793 characters.

### Evaluation of Disclosure Controls and Procedures

We have evaluated, under the supervision of our Chief Executive Officer (“CEO”) and our Chief Financial Officer (“CFO”), the effectiveness of disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”) as of September 30, 2019. Based on this evaluation, our CEO and CFO concluded that as of the end of the period covered by this report, our disclosure controls and procedures were effective.

Disclosure controls and procedures are controls and procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act (a) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (b) is accumulated and communicated to management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure. Our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Our disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives as described above.

### Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Filed Nov 12, 2019.
Source: SEC EDGAR, the filing index for accession 0001185185-19-001566. Last ingested by Listed: Nov 14, 2026, 21:35 ET. No prices; not investment advice.
